Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    Research Biologist and Contractor Charged in Bribery Scheme at DEVCOM Chemical Biological Center

    By Global Biodefense StaffFebruary 15, 2022
    Share
    Facebook LinkedIn Reddit Email

    Army Employee Alleged to Have Received Cash and Home Renovations in Exchange for Government Contracts

    A federal grand jury has returned an indictment charging Jason Edmonds, age 43, of North East, Maryland, with conspiracy and bribery.  Co-defendant John Conigliaro, age 60, of Kingsville, Maryland was separately charged with conspiracy in a 1 February 2022 filing.

    The Indictment against Edmonds was announced by United States Attorney for the District of Maryland Erek L. Barron; Special Agent in Charge Thomas J. Sobocinski of the Federal Bureau of Investigation, Baltimore Field Office; Special Agent in Charge Christopher Dillard of the Department of Defense Office of Inspector General; and Special Agent in Charge L. Scott Moreland of the Army Criminal Investigation Division.

    As stated in the Indictment, Edmonds was employed by the Army as a Research Biologist at the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM Chemical Biological Center), formerly known as the Edgewood Chemical Biological Center, located at the Aberdeen Proving Ground (APG). The DEVCOM Chemical Biological Center is the nation’s principal research and development center for non-medical chemical and biological weapons defense.  The DEVCOM Chemical Biological Center develops technology in the areas of detection, protection, and decontamination.

    According to the seven-count Indictment, from 2012 to 2019, Edmonds accepted cash and other financial benefits from John Conigliaro, the owner and CEO of EISCO, Inc. in exchange for favorable action on DEVCOM Chemical Biological Center contracts. For example, the Indictment alleges that in July 2013, Edmonds directed a $300,000 DEVCOM Chemical Biological Center project to EISCO. The Indictment alleges that, three months later, in October 2013, Conigliaro gave Edmonds $40,000 in cash so that Edmonds could purchase two rental real estate properties. Once Edmonds purchased the rental properties, the Indictment alleges that Conigliaro paid for thousands of dollars of renovations to the rental properties. The Indictment alleges that Edmonds executed a “Promissory Note,” in which Edmonds wrote that he repaid Conigliaro a portion of the funds that Conigliaro had given him with DEVCOM Chemical Biological Center projects.

    Additionally, the Indictment alleges that from 2016 to 2018, Edmonds directed four DEVCOM Chemical Biological Center projects to EISCO. Over that same time period, Conigliaro allegedly paid for more than $30,000 in renovations to Edmonds’ personal residence.

    Conigliaro is scheduled to appear for an initial appearance and arraignment on February 24, 2022 before U.S. District Judge Deborah L. Boardman.

    If convicted, Edmonds and Conigliaro face a maximum sentence of five years in federal prison for conspiracy, and Edmonds faces fifteen years in federal prison for bribery. Actual sentences for federal crimes are typically less than the maximum penalties. A federal district court judge will determine any sentence after taking into account the U.S. Sentencing Guidelines and other statutory factors.

    An indictment is not a finding of guilt.  An individual charged by indictment is presumed innocent unless and until proven guilty at some later criminal proceedings.

    United States Attorney Erek L. Barron commended the FBI, the Department of Defense Office of Inspector General, and the Army Criminal Investigation Division for their work in the investigation.  Mr. Barron thanked Assistant U.S. Attorneys Matthew P. Phelps and Harry Gruber, who are prosecuting the federal case.

    Source: Justice.gov

    ECBC Editor Pick
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleATCC Announces Awards from DTRA Supporting Global Health and Biodefense
    Next Article New GAO Report Addresses Nation’s Biodefense Programmatic Challenges

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.